Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoformulations for glioblastoma multiforme: a new hope for treatment
Raúl Ortíz, Laura Cabeza, Gloria Perazzoli, et al.
Future Medicinal Chemistry (2019) Vol. 11, Iss. 18, pp. 2461-2482
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Advances in Glioblastoma Therapy: An Update on Current Approaches
Ramcharan Singh Angom, Naga Malleswara Rao Nakka, Santanu Bhattacharya
Brain Sciences (2023) Vol. 13, Iss. 11, pp. 1536-1536
Open Access | Times Cited: 74
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
Raúl Ortíz, Gloria Perazzoli, Laura Cabeza, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 4, pp. 513-537
Open Access | Times Cited: 107
Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment
Marcela Tavares Luiz, Juliana Santos Rosa Viegas, Juliana Palma Abriata, et al.
Materials Science and Engineering C (2021) Vol. 124, pp. 112033-112033
Closed Access | Times Cited: 49
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
Leonardo Delello Di Filippo, Juliana H. Azambuja, Jessyca Aparecida Paes Dutra, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2021) Vol. 168, pp. 76-89
Closed Access | Times Cited: 46
PDA-Based Drug Delivery Nanosystems: A Potential Approach for Glioma Treatment
Hao Wu, Min Wei, Yu Xu, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 3751-3775
Open Access | Times Cited: 35
Multimodal targeting of glioma with functionalized nanoparticles
Hany E. Marei
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 29
Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
Neja Šamec, Alja Zottel, Alja Videtič Paska, et al.
Molecules (2020) Vol. 25, Iss. 3, pp. 490-490
Open Access | Times Cited: 40
Nanomedicine for glioblastoma: Progress and future prospects
Imran Khan, Mohammad Hassan Baig, Sadaf Mahfooz, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 172-186
Closed Access | Times Cited: 28
Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma
Xiaojie Chen, Yuyi Zheng, Qi Zhang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Highlights in targeted nanoparticles as a delivery strategy for glioma treatment
Marcela Tavares Luiz, Leonardo Delello Di Filippo, Larissa Bueno Tofani, et al.
International Journal of Pharmaceutics (2021) Vol. 604, pp. 120758-120758
Open Access | Times Cited: 30
Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?
Daniel Ruiz‐Molina, Xiaoman Mao, Paula Alfonso-Triguero, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4960-4960
Open Access | Times Cited: 20
Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities
Tanisha Gupta, Rakesh Kumar Sahoo, Himani Singh, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 4
Closed Access | Times Cited: 11
Intranasal delivery of poly (d-glucosamine) encrusted self-assembled lipidic nanovesicles to enhanced brain uptake of thymoquinone for management of Glioblastoma Multiforme
Sagar Trivedi, Suraj Kause, Veena S. Belgamwar
Journal of Drug Delivery Science and Technology (2023) Vol. 90, pp. 105149-105149
Closed Access | Times Cited: 11
Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art
Leonardo Delello Di Filippo, Jonatas Lobato Duarte, Marcela Tavares Luiz, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 6, pp. 787-812
Open Access | Times Cited: 30
Development of Artificial Plasma Membranes Derived Nanovesicles Suitable for Drugs Encapsulation
Carolina Martinelli, Fabio Gabriele, Elena Dini, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1626-1626
Open Access | Times Cited: 21
Genistein transfersome-embedded topical delivery system for skin melanoma treatment: in vitro and ex vivo evaluations
Amira Motawea, Sara N. Maria, Doaa Nabih Maria, et al.
Drug Delivery (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 2
LEF1-AS1 is implicated in the malignant development of glioblastoma via sponging miR-543 to upregulate EN2
Shi Zeng, Chun Hui Zhou, Donghong Yang, et al.
Brain Research (2020) Vol. 1736, pp. 146781-146781
Closed Access | Times Cited: 14
Liposomal Doxorubicin In vitro and In vivo Assays in Non-small Cell Lung Cancer: A Systematic Review
Pablo Redruello-Guerrero, Paula Córdoba-Peláez, Antonio Jesús Láinez Ramos‐Bossini, et al.
Current Drug Delivery (2023) Vol. 21, Iss. 10, pp. 1346-1361
Closed Access | Times Cited: 4
Naringenin Nanoformulations for Neurodegenerative Diseases
Liza Sahoo, Nigam Sekhar Tripathy, Fahima Dilnawaz
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 16, pp. 2108-2124
Closed Access | Times Cited: 1
Temozolomide: An Overview of Biological Properties, Drug Delivery Nanosystems, and Analytical Methods
Jessyca Aparecida Paes Dutra, Marcela Tavares Luiz, Alberto Gomes Tavares, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 25, pp. 2073-2088
Closed Access | Times Cited: 7
Investigation of apoptotic and antiproliferative effects of Turkish natural tetraploids Trifolium pratense L. extract on C6 glioblastoma cells via light and electron microscopy
Gamze Tanrıverdi, Aynur Abdulova, Hatice Çölgeçen, et al.
Ultrastructural Pathology (2023) Vol. 47, Iss. 3, pp. 160-171
Closed Access | Times Cited: 3
Surface Engineered Dendrimers: A Potential Nanocarrier for the Effective Management of Glioblastoma Multiforme
Rakesh Kumar Sahoo, Tanisha Gupta, Sanya Batheja, et al.
Current Drug Metabolism (2022) Vol. 23, Iss. 9, pp. 708-722
Closed Access | Times Cited: 5
Next‐generation agents for fluorescence‐guided glioblastoma surgery
Cristina Chirizzi, Serena Pellegatta, Alessandro Gori, et al.
Bioengineering & Translational Medicine (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 2
Case Report: H3K27M-Mutant Glioblastoma Simultaneously Present in the Brain and Long-Segment Spinal Cord Accompanied by Acute Pulmonary Embolism
Buajieerguli Maimaiti, Salamaitiguli Mijiti, Ting Jiang, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 4
Antitumor effects of natural molecules in the brain: a nanotechnology-based approach
Shrestha Sharma, Shobhit Kumar, Syed Arman Rabbani, et al.
Elsevier eBooks (2024), pp. 1989-2013
Closed Access
Page 1 - Next Page

Scroll to top